Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 3094-3099, June 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwalb, G.
Right arrow Articles by Nel, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwalb, G.
Right arrow Articles by Nel, A. E.

Promotion of DNA Strand Breaks in Cocultured Mononuclear Leukocytes by Protein Kinase C-dependent Prooxidative Interactions of Benoxaprofen, Human Polymorphonuclear Leukocytes, and Ultraviolet Radiation1

Gwen Schwalb, Albertus D. Beyers, Ronald Anderson2 and Andre E. Nel

Division of Immunology, Department of Medical Microbiology, Institute of Pathology, University of Pretoria [G. S., R. A.]; and the Departments of Medical Physiology [A. D. B.] and Internal Medicine [A. E. N.], Faculty of Medicine, University of Stellenbosch, Tygerberg; Republic of South Africa

At concentrations of 5 µg/ml and greater the nonsteroidal antiinflammatory drug benoxaprofen caused dose-related activation of lucigeninenhanced chemiluminescence in human polymorphonuclear leukocytes (PMNL). Benoxaprofen-mediated activation of lucigenin-enhanced chemiluminescence by PMNL was increased by UV radiation and was particularly sensitive to inhibition by the selective protein kinase C inhibitor H-7. To identify the molecular mechanism of the prooxidative activity of benoxaprofen, the effects of the nonsteroidal antiinflammatory drug on the activity of purified protein kinase C in a cell-free system were investigated. Benoxaprofen caused a dose-related activation of protein kinase C by interaction with the binding site for the physiological activator phosphatidylserine, but could not replace diacylglycerol. When autologous mononuclear leukocytes (MNL) were cocultured with PMNL and benoxaprofen in combination, but not individually, the frequency of DNA strand breaks in MNL was markedly increased. UV radiation significantly potentiated damage to DNA mediated by benoxaprofen and PMNL. Inclusion of superoxide dismutase, H-7, and, to a much lesser extent, catalase during exposure of MNL to benoxaprofen-activated PMNL prevented oxidant damage to DNA. These results clearly demonstrate that potentially carcinogenic prooxidative interactions, which are unlikely to be detected by conventional assays of mutagenicity, may occur between phagocytes, UV radiation, and certain pharmacological agents.

1 This investigation was supported by individual investigator research grants awarded by the National Cancer Association and the Arthritis Foundation of South Africa to R. Anderson and by The South African Medical Research Council to A. E. Nel.

2 To whom requests for reprints should be addressed, at Institute of Pathology, P. O. Box 2034, Pretoria 0001, Republic of South Africa.

Received 10/23/87. Revised 2/11/88. Accepted 3/ 3/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.